Retatrutide 40

once weekly · 133 µg na cvaknutí · 300 cvaknutí na pero

Retatrutide 40

once weekly · 133 µg na cvaknutí · 300 cvaknutí na pero

fáze 01 Zástupný obrázek, pero na počáteční dávce

weeks 1–4 the on-ramp

2 mg · 15 cvaknutí

once weekly · same day each week

Published titration protocols open at the lowest full dose so tolerance can be mapped before capacity is raised. The first four weeks are a tolerance window, not a results window, the reference schedule holds here deliberately.

✦dose the same weekday each week, consistency over timing

✦a fresh needle every administration, pen back to 2–8 °C

✦log the batch number against the published COA before first use

weeks 4–8 the step up

4 mg · 30 cvaknutí

once weekly · double the clicks, same ritual

Once the on-ramp is comfortable, the reference schedule doubles the click count. This is the band where the phase-2 curve begins to move in the literature. If tolerance markers linger, the printed card holds the lower dose for another fortnight.

✦step up only after four settled weeks, never earlier

✦the triple agonist raises energy expenditure; hydration matters more here

✦track weekly, not daily, the trend is the signal

fáze 02 Zástupný obrázek, kolečko na zvýšené dávce

fáze 03 Zástupný obrázek, plná referenční dávka

weeks 8+ the reference dose

8 mg · 60 cvaknutí

once weekly · hold and let the weeks compound

The full reference dose, and the ceiling on this pen. It is reached by titration, never started cold. From week eight the variable that matters is consistency: same day, same clicks, held long enough for the data to accrue.

✦this is the maximum, more clicks is not more result

✦a missed week: within four days or skip, never double

✦reorder at roughly two weeks of clicks remaining so the cold chain never breaks

Retatrutide 40 → Metabolismus & Hmotnost → Advanced Lean Stack →Advanced Summer Stack →Advanced Metabolic Reset →

✦ Tento průvodce reprodukuje tištěnou dávkovací kartu a publikovanou výzkumnou titraci, je referencí pro laboratorní výzkum, nikoli lékařskou radou. Před použitím si přečtěte oznámení o výzkumném použití.

průvodce dávkováním